{
    "eid": "2-s2.0-85058742898",
    "title": "Role of mucoprotective agents in endoscopic submucosal dissection-derived ulcers: A systematic review",
    "cover-date": "2018-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hepatology",
            "@code": "2721",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Gastroenterology",
            "@code": "2715",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Healing",
        "Mucoprotective agent",
        "Post-gastric ESD",
        "PPI",
        "Ulcer"
    ],
    "authors": [
        "Rapat Pittayanon",
        "Myriam Martel",
        "Alan Barkun"
    ],
    "citedby-count": 5,
    "ref-count": 41,
    "ref-list": [
        "Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry",
        "Endoscopic submucosal dissection allows curative resection of locally recurrent early gastric cancer after prior endoscopic mucosal resection",
        "Effects of preoperative proton pump inhibitor administration on bleeding after gastric endoscopic submucosal dissection: A systematic review and meta-analysis",
        "Practice Parameters Committee of the American College of G. Guidelines for prevention of NSAID-related ulcer complications",
        "Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: Results of a double-blind, randomized, multicenter, active-and placebo-controlled study of misoprostol vs lansoprazole",
        "Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: A prospective randomized controlled trial",
        "Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: A meta-analysis of randomized trials",
        "Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1",
        "Rebamipide, a gastroprotective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: A randomized, double-blind, placebo-controlled trial",
        "Sucralfate in clinical practice",
        "Differential effects of misoprostol and ranitidine on the pharmacokinetics of diclofenac and gastrointestinal symptoms",
        "Rebamipide: A gastrointestinal protective drug with pleiotropic activities",
        "Roles of prostaglandins, nitric oxide and the capsaicin-sensitive sensory nerves in gastroprotection produced by ecabet sodium",
        "Expert consensus on perioperative medications during endoscopic submucosal dissection for gastric lesions (2015, Suzhou, China)",
        "Efficacy and safety of proton pump inhibitors (PPIs) plus rebamipide for endoscopic submucosal dissection-induced ulcers: A meta-analysis",
        "Proton pump inhibitor alone vs proton pump inhibitor plus mucosal protective agents for endoscopic submucosal dissection-induced ulcer: A systematic review and meta-analysis",
        "A second-look endoscopy after endoscopic submucosal dissection for gastric epithelial neoplasm may be unnecessary: A retrospective analysis of postendoscopic submucosal dissection bleeding",
        "Random-effects models for longitudinal data",
        "Quantitative synthesis in systematic reviews",
        "Quantifying heterogeneity in a meta-analysis",
        "Combination of proton pump inhibitor and rebamipide, a free radical scavenger, promotes artificial ulcer healing after endoscopic submucosal dissection with dissection size >40 mm",
        "Toyonaga Tet al. A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection",
        "Clinical trial: Rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection\u2014a randomized controlled study",
        "Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide",
        "The effect of short-term proton pump inhibitor plus anti-ulcer drug on the healing of endoscopic submucosal dissection-derived artificial ulcer: A randomized controlled trial",
        "Limited effect of rebamipide in addition to proton pump inhibitor (PPI) in the treatment of post- endoscopic submucosal dissection gastric ulcers: A randomized controlled trial comparing PPI plus rebamipide combination therapy with PPI monotherapy",
        "Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study",
        "Comparison of an ecabet sodium and proton pump inhibitor (PPI) combination therapy with PPI alone in the treatment of endoscopic submucosal dissection (ESD)--induced ulcers in early gastric cancer: Prospective randomized study",
        "Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers",
        "Comparison of the efficacy of lansoprazole and lansoprazole plus ecabet sodium in the treatment of iatrogenic gastric ulcers after endoscopic submucosal dissection",
        "Can irsogladine maleate, a mucosal protective drug, promotes the healing of ulcers after endoscopic submucosal dissection? A randomized, prospective, multicenter study",
        "Efficacy of combination therapy with polaprezinc plus proton pump inhibitor for gastric ulcer after endoscopic submucosal dissection",
        "Basal protrusion of ulcers induced by endoscopic submucosal dissection (ESD) during treatment with proton pump inhibitors, and the suppressive effects of polaprezinc",
        "Long-term outcome of early gastric cancer after endoscopic submucosal dissection: Expanded indication is comparable to absolute indication",
        "Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats",
        "Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants",
        "Rebamipide-promoted restoration of gastric mucosal sonic hedgehog expression after early Helicobacter pylori eradication",
        "Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: A key to its ulcer healing action?",
        "Helicobacter pylori status and the extent of gastric atrophy do not affect ulcer healing after endoscopic submucosal dissection"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Montreal",
            "@id": "60006558",
            "affilname": "Centre Universitaire de Sant\u00e9 McGill",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006558",
            "affiliation-country": "Canada"
        }
    ],
    "funding": []
}